Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,89 USD | +3,73% | +5,94% | -7,40% |
25/03 | Transcript : Daxor Corporation, 2023 Earnings Call, Mar 25, 2024 | |
25/03 | Daxor neemt Volumex en Megatope over om Diagnostics Suite uit te breiden | MT |
Omzet 2022 | 232K 215K | Omzet 2023 | 163K 152K | Marktkapitalisatie | 46,01 mln. 42,7 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 5 mln. 4,64 mln. | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 174 x |
Nettoschuld 2022 | 1,23 mln. 1,14 mln. | Nettoschuld 2023 | 756K 701K | EV/omzet 2023 | 286 x |
K/w-verhouding 2022 |
7,59
x | K/w-verhouding 2023 |
164
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 38,69% |
Recentste transcriptie over Daxor Corporation
1 week | +9,75% | ||
Lopende maand | +12,68% | ||
1 maand | +19,33% | ||
3 maanden | +1,72% | ||
6 maanden | -6,91% | ||
Lopend jaar | -7,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Robert Michel
DFI | Director of Finance/CFO | 67 | 28-09-18 |
Linda Cooper
COO | Chief Operating Officer | - | 17-02-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Lombard
BRD | Director/Board Member | 89 | 01-01-89 |
Chief Executive Officer | 54 | 01-01-13 | |
Chief Tech/Sci/R&D Officer | 59 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 8,89 | +3,73% | 6 454 |
27-03-24 | 8,57 | -0,64% | 2 967 |
26-03-24 | 8,625 | -2,76% | 2 429 |
25-03-24 | 8,87 | +6,74% | 3 313 |
22-03-24 | 8,31 | +2,59% | 1 293 |
uitgestelde koers Nyse, 28 maart 2024 om 21:30 uur
Meer koersenChiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,94% | 12,43 mld. | |
+11,21% | 9,4 mld. | |
-4,51% | 5,31 mld. | |
+7,47% | 5,26 mld. | |
-1,27% | 5,2 mld. | |
+8,59% | 4,17 mld. | |
+3,05% | 4,14 mld. | |
+2,60% | 3,98 mld. | |
+1,56% | 3,8 mld. |
- Beurs
- Aandelen
- Aandeel Daxor Corporation
- Aandeel Daxor Corporation - Nyse